1 completed, 1 suspended, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Suspended 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Suspended 1 |
Follow talactoferrin alfa: new trials by email Literature Review of talactoferrin alfa trials Research Report on talactoferrin alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis Talactoferrin alfa, Placebo - Severe Sepsis | Phase 2 / Phase 3 | Suspended | Agennix | 1280 | 2011-06-01 | 2012-02-03 |
| Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants Talactoferrin, Placebo - Nosocomial Infections | Phase 1 / Phase 2 | Unknown | Agennix | 120 | 2009-06-01 | 2012-03-15 |
| Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis Talactoferrin alfa, Placebo - Severe Sepsis | Phase 2 | Completed | Agennix | 190 | 2008-04-01 | 2011-08-23 |
Sepsis (2) · Cross Infection (1)
Agennix (3)
United States (3) · Canada (2) · France (2) · Germany (2) · Spain (2) · Belgium (1) · Denmark (1) · Israel (1) · Netherlands (1) · United Kingdom (1)
Kalpalatha K Guntupalli, MD (1)
PMID 23425819, PMID 26010687, PMID 27234409, PMID 27260839
R44HD057744 (1)